Konwar, M., Bose, D., Jaiswal, S
Importantly, supplementation can **increase** measurable NAD+ metabolism: in a 2018 randomized, placebo-controlled crossover trial published in Nature Communications by Martens and colleagues at the University of Colorado Boulder (24 healthy middle-aged and older adults), 1,000 mg/day of the NAD+ precursor nicotinamide riboside (500 mg, twice daily) elevated NAD+ in blood cells by roughly 60% versus placebo over 6 weeks, with no serious adverse events reported
3AG), except for marginal improvement of insulin resistance, denoted by a modest reduction of HOMA-IR (Fig
Oparaugo NC, Ouyang K, Nguyen NPN, Nelson AM, Agak GW